Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1984-01-05
1984-10-23
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
424 16, 424 19, 424 22, 424 28, 424 75, 424238, 424239, 424240, 424241, 424242, 424243, A61K 900, A61K 926, A61K 31565, A61K 3174
Patent
active
044788185
ABSTRACT:
An ocular insert and an ocular composition are disclosed. The insert and the composition comprises a steroid in two different forms.
REFERENCES:
patent: 2932606 (1960-04-01), Shull et al.
patent: 2978379 (1961-04-01), Shell
patent: 3073743 (1963-01-01), Spero
patent: 3105795 (1963-10-01), Nobile
patent: 3134718 (1964-05-01), Nobile
patent: 3138527 (1974-06-01), Spero
patent: 3197367 (1965-07-01), Panzarella
patent: 3536809 (1970-10-01), Applezweig
patent: 3743741 (1973-07-01), Laurent et al.
patent: 3780176 (1973-12-01), Young
patent: 3863633 (1975-02-01), Ryde et al.
patent: 3867519 (1975-02-01), Michael
patent: 3868445 (1975-02-01), Ryde et al.
patent: 3923939 (1975-02-01), Baker et al.
patent: 3934013 (1976-01-01), Poulsen
patent: 3961628 (1976-06-01), Arnold
patent: 3962414 (1976-06-01), Michaels
patent: 3968201 (1976-07-01), Ryde et al.
patent: 4001388 (1977-01-01), Shell
patent: 4052505 (1977-10-01), Higuchi et al.
patent: 4057619 (1977-11-01), Higuchi et al.
patent: 4115544 (1978-09-01), Shell
patent: 4164559 (1979-08-01), Miyata et al.
patent: 4177256 (1979-12-01), Michaels et al.
patent: 4179497 (1979-12-01), Cohen et al.
patent: 4186184 (1980-01-01), Zaffaroni
patent: 4304765 (1981-12-01), Shell et al.
Higuchi et al., J. Pharm. Sci., vol. 52, No. 1, pp. 67-71, 1963, Dissolution Rates of Finely Divided Powders, 1, Effect of a Distribution of Particle Sizes in a Diffusion-Controlled Process.
Higuchi et al., J. Pharm. Sci., vol. 52, No. 2, pp. 150-159, 1963, Polymorphism and Drug Availability, Solubility Relationships in Methylprednisolone System.
Higuchi et al., J. Pharm. Sci., vol. 52, No. 2, pp. 162-164, 1963, Dissolution Rates of Finely Divided Drug Powders II, Micronized Methylprednisolone.
Haleblian et al., J. Pharm. Sci., vol. 58, No. 8, pp. 911-929, 1969, Pharmaceutical Applications of Polymorphism.
Haleblian et al., J. Pharm. Sci., vol. 60, No. 10, pp. 1485-1491, 1971, Isolation and Characterization of Some Solid Phases of Fluprednisolone.
Haleblian, J. Pharm. Sci., vol. 64, No. 8, pp. 1269-1288, 1975, Characterization of Habits and Crystalline Modifications of Solids and Their Pharmaceutical Applications.
Gale Robert M.
Shell John W.
ALZA Corporation
Mandell Edward L.
Rose Shep K.
Sabatine Paul L.
Stone Steven F.
LandOfFree
Ocular preparation housing steroid in two different therapeutic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ocular preparation housing steroid in two different therapeutic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ocular preparation housing steroid in two different therapeutic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1598606